Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma
(12 March, 2011)
Betty Gardie, Audrey Remenieras, Darouna Kattygnarath, Johny Bombled, Sandrine Lefèvre, Victoria Perrier-Trudova, Pierre Rustin, Michel Barrois, Abdelhamid Slama, Marie-Françoise Avril, Didier Bessis, Olivier Caron, Frédéric Caux, Patrick Collignon, Isabelle Coupier, Carol Cremin, Hélène Dollfus, Catherine Dugast, Bernard Escudier, Laurence Faivre, Michel Field, Brigitte Gilbert-Dussardier, Nicolas Janin, Yves Leport, Dominique Leroux, Dan Lipsker, Félicia Malthieu, Barbara McGilliwray, Christine Maugard, Arnaud Méjean, Isabelle Mortemousque, Ghislaine Plessis, Bruce Poppe, Christelle Pruvost-Balland, Serena Rooker, Joelle Roume, Nadem Soufir, Michelle Steinraths, Min-Han Tan, Christine Théodore, Luc Thomas, Pierre Vabres, Emmanuel Van Glabeke, Jean-Baptiste Meric, Virginie Verkarre, Gilbert Lenoir, Virginie Joulin, Sophie Deveaux, Veronica Cusin, Jean Feunteun, Bin Tean Teh, Brigitte Bressac-de Paillerets, Stéphane Richard
Commentary